CMS Manual System

[Pages:22]CMS Manual System

Pub. 100-04 Medicare Claims Processing

Transmittal 325

Department of Health & Human Services (DHHS) Centers for Medicare & Medicaid Services (CMS) Date: OCTOBER 22, 2004

CHANGE REQUEST 3484

I. SUMMARY OF CHANGES:

This instruction informs contractors of new waived tests approved by the Food and Drug Administration under Clinical Laboratory Improvement Amendments of 1988. Since these tests are marketed immediately after approval, the Centers for Medicare and Medicaid Services must notify its contractors of the new tests so that the contractors can accurately process claims.

NEW/REVISED MATERIAL - EFFECTIVE DATE: January 3, 2005 *IMPLEMENTATION DATE: January 3, 2005

II. CHANGES IN MANUAL INSTRUCTIONS: (R = REVISED, N = NEW, D = DELETED ?

R/N/D CHAPTER/SECTION/SUBSECTION/TITLE N/A

III. FUNDING: *Medicare contractors only: These instructions shall be implemented within your current operating budget.

IV. ATTACHMENTS:

Business Requirements Manual Instruction Confidential Requirements One-Time Notification X Recurring Update Notification

Attachment - Recurring Update Notification

Pub. 100-04 Transmittal: 325 Date: October 22, 2004 Change Request 3484

Subject: New Waived Tests ? January 1, 2005 I. GENERAL INFORMATION

A. Background:

The Clinical Laboratory Improvement Amendments of 1988 (CLIA) regulations require a facility to be appropriately certified for each test performed. To ensure that Medicare and Medicaid only pay for laboratory tests categorized as waived complexity under CLIA in facilities with a CLIA certificate of waiver, laboratory claims are currently edited at the CLIA certificate level.

Listed below are the latest tests approved by the Food and Drug Administration as waived tests under the CLIA. The Current Procedural Terminology (CPT) codes for the following new tests must have the modifier QW to be recognized as a waived test. However, the tests mentioned on the first page of the attached list (i.e., CPT codes: 81002, 81025, 82270, G0107, 82962, 83026, 84830, 85013, and 85651) do not require a QW modifier to be recognized as a waived test.

CPT Code/Modifier 87804QW 87880QW

87880QW 84450QW 87880QW 83001QW

85018QW

82465QW, 83718 QW, 84478 QW, 80061QW 87880QW 80101QW

80101QW

Effective Date 2-6-2004 4-15-2004

6-4-2004 6-18-2004 6-28-2004 6-28-2004

6-30-2004

7-9-2004

Description Quidel Quickvue Influenza A+B Test

DE Healthcare Products TruView Strep A Cassette Test Polymedco Poly Stat Strep A Liquid Test

Cholestech LDX (Whole Blood)

Immunostics Detector Strep A Direct

Acon Laboratories, Inc. FSH Menopause Predictor Test HemoCue Hemoglobin 201+ (Capillary, Venous, Arterial Whole Blood) Piccolo Point of Care Chemistry Analyzer (Lipid Panel Reagent Disc) (Whole Blood)

7-15-2004 8-24-2004

8-24-2004

Genzyme OSOM Ultra Strep A Test

Accu-Stat Drugs of Abuse Home Test for Marijuana (THC) and Cocaine (COC) Accu-Stat Drugs of Abuse Home Test for Marijuana (THC)

The new waived code, 84450QW, has been assigned for the aspartate aminotransferase (AST) test performed on the Cholestech LDX (Whole Blood) test system.

B. Policy:

The CLIA regulations require a facility to be appropriately certified for each test performed. To ensure that Medicare and Medicaid only pay for laboratory tests

categorized as waived complexity under CLIA in facilities with a CLIA certificate of waiver, laboratory claims are currently edited at the CLIA certificate level.

C. Provider Education: None.

II. BUSINESS REQUIREMENTS

"Shall" denotes a mandatory requirement "Should" denotes an optional requirement

Requirement Requirements Number

3484.1

The Medicare contractor shall include the new tests listed above in CLIA-covered code files with the QW modifier.

Responsibility ("X" indicates the

columns that apply)

F R C D Shared System Other

I H a M Maintainers

Hr I r

i e r

E R C

F I S

S

MV C C MW S S F

X

3484.2

The Medicare contractor shall permit the use to

X

X

the code 84450QW for claims submitted by

facilities with a valid current CLIA certificate

of waiver with dates of services on or after June

18, 2004.

3484.3

Contractors need not search their files to either

X

retract payment or retroactively pay claims,

however, contractors should adjust claims if

they are brought to their attention.

III. SUPPORTING INFORMATION AND POSSIBLE DESIGN CONSIDERATIONS

A. Other Instructions:

The attachment contains the complete list of waived tests, including the new waived tests listed previously. In the attachment, the information in the "Use" column explains the purpose of the waived test. If denial is appropriate, this explanation is unacceptable to use as the reason for the denial of a claim. Use the appropriate remittance advice message that describes why the test was denied.

X-Ref Requirement # Instructions

B. Design Considerations: N/A X-Ref Requirement # Recommendation for Medicare System Requirements

C. Interfaces: N/A

D. Contractor Financial Reporting /Workload Impact: N/A

E. Dependencies: N/A

F. Testing Considerations: N/A

IV. SCHEDULE, CONTACTS, AND FUNDING Effective Date: January 3, 2005 Implementation Date: January 3, 2005 Pre-Implementation Contact(s): Kathy Todd (410) 786-3385 Post-Implementation Contact(s): Kathy Todd (410) 786-3385

Medicare contractors shall implement these instructions within their current operating budgets.

Attachment

TESTS GRANTED WAIVED STATUS UNDER CLIA

CPT CODE(S)

81002

TEST NAME

MANUFACTURER

Dipstick or tablet reagent urinalysis ? non-automated for bilirubin, glucose, hemoglobin, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen

Various

USE

Screening of urine to monitor/diagnose various diseases/conditions, such as diabetes, the state of the kidney or urinary tract, and urinary tract infections

81025

Urine pregnancy tests by visual color comparison

82270 G0107 (Contact your Medicare carrier for claims instructions.)

Fecal occult blood

82962

Blood glucose by glucose monitoring devices cleared by the FDA for home use

83026

Hemoglobin by copper sulfate ? nonautomated

84830

Ovulation tests by visual color comparison for human luteinizing hormone

85013

Blood count; spun microhematocrit

85651

Erythrocyte sedimentation rate ? nonautomated

Various Various

Various Various Various Various Various

Diagnosis of pregnancy Detection of blood in feces from whatever cause, benign or malignant (colorectal cancer screening)

Monitoring of blood glucose levels

Monitors hemoglobin level in blood Detection of ovulation (optimal for conception)

Screen for anemia Nonspecific screening test for inflammatory activity, increased for majority of infections, and most cases of carcinoma and leukemia

This list includes updates through 9/8/2004

TESTS GRANTED WAIVED STATUS UNDER CLIA

CPT CODE(S)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

TEST NAME

1. Phamatech At Home Drug Test (Model 9063)

2. Phamatech QuickScreen One Step Amphetamine Test

1. Accu-Stat Drugs of Abuse Home Test for Marijuana (THC)*

2. ADC CLIA Waived Marijuana (THC) Test

3. Phamatech At Home Drug Test (Model 9078)

4. Phamatech At Home Drug Test (Model 9078T)

5. Worldwide Medical Corporation, First Check? Home Drug Test (THC)

1. Phamatech At Home Drug Test (Model 9073)

2. Phamatech At Home Drug Test (Model 9073T)

3. Phamatech QuickScreen One Step Cocaine Screening Test

MANUFACTURER

Phamatech

Phamatech Accu-Stat Diagnostics, Inc.

Advantage Diagnostics Corporation (ADC) Phamatech Phamatech Worldwide Medical Corporation Phamatech

Phamatech Phamatech

USE

Screening test for the presence/detection of amphetamine in urine Screening test for the presence/detection of cannabinoids (THC) in urine

Screening test for the presence/detection of cocaine metabolites in urine

This list includes updates through 9/8/2004

2

* Newly added waived test system

TESTS GRANTED WAIVED STATUS UNDER CLIA

CPT CODE(S)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.) 80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

TEST NAME

1. Phamatech At Home Drug Test (Model 9068)

2. Phamatech QuickScreen One Step Methamphetamine Test

DynaGen NicCheck I Test Strips

1. Phamatech At Home Drug Test (Model 9083)

2. Phamatech QuickScreen One Step Opiate Screening Test

1. Phamatech At Home Drug Test (Model 9133)

2. Phamatech QuickScreen One Step PCP Screening Test

MANUFACTURER

Phamatech

Phamatech Dynagen, Inc.

Phamatech

Phamatech Phamatech

Phamatech

USE

Screening test for the presence/detection of methamphetamines in urine

Detects nicotine and/or its metabolites in urine, which is used as an aid in indicating the smoking status of an individual and as an aid in the identification of a smoker as a low or high nicotine consumer Screening test for the presence/detection of opiates in urine

Screening test for the presence/detection of phencyclidine in urine

This list includes updates through 9/8/2004

3

* Newly added waived test system

TESTS GRANTED WAIVED STATUS UNDER CLIA

CPT CODE(S)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

80101QW (This test may not be covered in all instances. Contact your Medicare carrier for claims instructions.)

TEST NAME

1. Accu-Stat Drugs of Abuse Home Test for Marijuana (THC) and Cocaine (COC)*

MANUFACTURER

Accu-Stat Diagnostics, Inc.

2. Advantage Diagnostics Advantage Marijuana (THC) and Cocaine Home Drug Test

3. ADC CLIA Waived Marijuana (THC) and Cocaine Test

4. Forefront Diagnostics Drugfree@Home THC/COC Test Kit

5. Worldwide Medical Corporation, First Check? Home Drug Test (THC-COC)

1. ADC CLIA Waived Multiple Drug Test Card

ADC

ADC Forefront Diagnostics, Inc.

Worldwide Medical Corporation ADC

2. Advantage Diagnostics Corporation ADC Multiple Drug Test Card

3. Alatex Scientific Peace of Mind Multiple Drugs of Abuse Test

Phamatech At Home Drug Test (Model 9150T)

Advantage Diagnostics Corporation

Advantage Diagnostics Corporation Phamatech

This list includes updates through 9/8/2004 * Newly added waived test system

USE

Screening test for the presence/detection of cannabinoids (THC) and cocaine metabolites in urine

Screening test for the presence/detection of cannabinoids (THC), cocaine metabolites, methamphetamines, opiates, and phencyclidine (PCP) in urine

Screening test for the presence/detection of amphetamines, cannabinoids (THC), cocaine metabolites, methamphetamines, and opiates in urine

4

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download